- 5 Ergebnisse
Kleinster Preis: € 74,89, größter Preis: € 160,49, Mittelwert: € 112,14
1
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Bestellen
bei Springer.com
€ 160,49
Bestellengesponserter Link
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:

Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - neues Buch

ISBN: 9783642281600

This important book provides up-to-date information on a series of topical issues relating to the approach to minimal residual disease in breast cancer patients. It first explains how the… Mehr…

new in stock. Versandkosten:zzgl. Versandkosten.
2
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) (English Edition)
Bestellen
bei amazon.de
€ 74,89
Versand: € 0,001
Bestellengesponserter Link
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) (English Edition) - neues Buch

2012, ISBN: 9783642281600

Springer, Kindle Ausgabe, Auflage: 2012, 456 Seiten, Publiziert: 2012-04-23T00:00:00.000Z, Produktgruppe: Digital Ebook Purchas, Chirurgie, Medizin, Kategorien, Bücher, Geburtshilfe & Per… Mehr…

Versandkosten:Jetzt als Download verfügbar. (EUR 0.00) Amazon Media EU S.à r.l.
3
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195)
Bestellen
bei amazon.co.uk
£ 94,99
(ca. € 111,35)
Versand: € 5,251
Bestellengesponserter Link
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer (Recent Results in Cancer Research Book 195) - neues Buch

2012

ISBN: 9783642281600

Editor: Ignatiadis, Michail, Editor: Sotiriou, Christos, Editor: Pantel, Klaus, Springer, Kindle Edition, Auflage: 2012, 456 Seiten, Publiziert: 2012-04-23T00:00:00.000Z, Produktgruppe: D… Mehr…

Versandkosten:Available for download now. (EUR 5.25) Amazon Media EU S.à r.l.
4
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Bestellen
bei lehmanns.de
€ 106,99
Versand: € 0,001
Bestellengesponserter Link
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - neues Buch

2012, ISBN: 9783642281600

eBooks, eBook Download (PDF), 2012, [PU: Springer Berlin], Seiten: 254, Springer Berlin, 2012

Versandkosten:Download sofort lieferbar. (EUR 0.00)
5
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Bestellen
bei lehmanns.de
€ 106,99
Versand: € 0,001
Bestellengesponserter Link
Michail Ignatiadis; Christos Sotiriou; Klaus Pantel:
Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer - neues Buch

2012, ISBN: 9783642281600

eBooks, eBook Download (PDF), 2012, [PU: Springer Berlin], Springer Berlin, 2012

Versandkosten:Download sofort lieferbar. (EUR 0.00)

1Da einige Plattformen keine Versandkonditionen übermitteln und diese vom Lieferland, dem Einkaufspreis, dem Gewicht und der Größe des Artikels, einer möglichen Mitgliedschaft der Plattform, einer direkten Lieferung durch die Plattform oder über einen Drittanbieter (Marketplace), etc. abhängig sein können, ist es möglich, dass die von eurobuch angegebenen Versandkosten nicht mit denen der anbietenden Plattform übereinstimmen.

Bibliographische Daten des bestpassenden Buches

Details zum Buch

Detailangaben zum Buch - Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer


EAN (ISBN-13): 9783642281600
ISBN (ISBN-10): 3642281605
Erscheinungsjahr: 2012
Herausgeber: Springer Berlin
253 Seiten
Sprache: eng/Englisch

Buch in der Datenbank seit 2007-08-16T08:57:27+02:00 (Berlin)
Detailseite zuletzt geändert am 2024-02-11T15:46:25+01:00 (Berlin)
ISBN/EAN: 9783642281600

ISBN - alternative Schreibweisen:
3-642-28160-5, 978-3-642-28160-0
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: christ klaus, pant, pantel, michail, ign, christos, sotiriou
Titel des Buches: res, min, mini, cancer, tum, cel, beyond the minimal, residu, minim, tumor


Daten vom Verlag:

Autor/in: Michail Ignatiadis; Christos Sotiriou; Klaus Pantel
Titel: Recent Results in Cancer Research; Minimal Residual Disease and Circulating Tumor Cells in Breast Cancer
Verlag: Springer; Springer Berlin
254 Seiten
Erscheinungsjahr: 2012-04-23
Berlin; Heidelberg; DE
Gedruckt / Hergestellt in Niederlande.
Sprache: Englisch
106,99 € (DE)
110,00 € (AT)
130,00 CHF (CH)
Available
XIV, 254 p.

EA; E107; eBook; Nonbooks, PBS / Medizin/Klinische Fächer; Onkologie; Verstehen; Breast cancer; Circulating nucleic acids; Circulating tumor cells; Micrometastasis; Minimal residual disease; surgical oncology; C; Oncology; Gynecology; Surgical Oncology; Pathology; Cancer Research; Oncology; Gynecology; Cancer Therapy; Pathology; Cancer Biology; Medicine; Gynäkologie und Geburtshilfe; Pathologie; BB

Minimal residual disease and circulating tumor cells in breast cancer: Open questions for research.- Minimal residual disease and breast cancer metastasis.- Self-seeding in cancer.- Microenvironments dictating tumor cell dormancy.- Technologies for circulating tumor cell (CTC) and disseminated tumor cell (DTC) detection and characterization.- Immunomagnetic separation technologies.- Microfluidic technologies for the isolation of CTCs.- EPISPOT assay: Detection of viable disseminating tumor cells in solid tumor patients.- Advances in optical technologies for rare cell detection and characterization.- Size-based enrichment technologies for circulating tumor cell (CTC) detection and characterization.- Emerging technologies for CTC detection based on depletion of normal cells.- Molecular assays for the detection and characterization of CTCs.- Multiplex molecular analysis of CTCs.- Other blood-based biomarkers.- Circulating DNA and next generation sequencing.- Circulating microRNAs as non-invasive biomarkers in breast cancer.- Circulating endothelial cells and circulating endothelial progenitors.- Disseminated tumor cells (DTCs) and circulating tumor cells (CTCs) in breast cancer clinical research and practice.- Bone marrow DTCs.- CTCs in primary breast cancer.- CTCs in early breast cancer.- CTCs in metastatic breast cancer.- HER2-positive DTCs/CTCs in breast cancer.- DTCs and CTCs in breast cancer – 5 decades later.- Drug and circulating tumor cell co-development.- Challenges in drug and biomarker co-development.- Challenges and opportunities in the use of CTCs for companion diagnostic development.

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers

Includes supplementary material: sn.pub/extras

Provides up-to-date information on topical issues concerning minimal residual disease in breast cancer patients

Appraises the technologies available for detection and characterization of circulating and disseminated tumor cells (CTCs/DTCs)

Discusses the relevance of CTCs and DTCs in breast cancer clinical research and practice, and the role of other blood-based biomarkers



< zum Archiv...